Perspectives of glycemic variability in diabetic neuropathy: a comprehensive review

Commun Biol. 2021 Dec 7;4(1):1366. doi: 10.1038/s42003-021-02896-3.


Diabetic neuropathy is one of the most prevalent chronic complications of diabetes, and up to half of diabetic patients will develop diabetic neuropathy during their disease course. Notably, emerging evidence suggests that glycemic variability is associated with the pathogenesis of diabetic complications and has emerged as a possible independent risk factor for diabetic neuropathy. In this review, we describe the commonly used metrics for evaluating glycemic variability in clinical practice and summarize the role and related mechanisms of glycemic variability in diabetic neuropathy, including cardiovascular autonomic neuropathy, diabetic peripheral neuropathy and cognitive impairment. In addition, we also address the potential pharmacological and non-pharmacological treatment methods for diabetic neuropathy, aiming to provide ideas for the treatment of diabetic neuropathy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Blood Glucose / analysis*
  • Diabetic Neuropathies / diagnosis
  • Diabetic Neuropathies / etiology
  • Diabetic Neuropathies / physiopathology*
  • Humans


  • Blood Glucose